Analyst: This Middle East crisis may be different; I recommend not buying any falling stocks right away.
Svmuu News: The situation has grown increasingly chaotic as Iran launched missiles at U.S. military bases in Gulf cities, airlines suspended flights, and oil tankers carrying oil and other products halted their passage through the Strait of Hormuz. Rong Ren Goh, portfolio manager of the fixed income team at Hanhua Investment, stated that tail risks in the Middle East have increased. The market will reprice, shifting from a geopolitical shock to a regime risk shock and a prolonged conflict—rather than merely retaliatory actions—unless Iran expresses a willingness to negotiate. Analysts believe that a greater risk lies in market complacency. Markets have consistently assumed that the impact of the conflict would be limited and have been reluctant to draw parallels between this conflict and the 1979 Iranian regime change. Barclays analysts noted that history strongly demonstrates that one should not chase rallies when conflict erupts, but rather “sell the fact.” However, the concern is that investors have now become accustomed to this “sell the fact” mindset and may be underestimating the risk of the situation spiraling out of control. It is advised not to buy into any pullbacks immediately. If the market corrects sufficiently—for example, if the S&P 500 falls by more than 10%—a buying opportunity may emerge. But now is not the time. (Jin Shi)
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
2
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
3
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
4
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
5
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
6
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
7
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
8
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
-
9
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
10
TRIVIA Coin: Originally Designed to Create a Blockchain-Based Trivia Game—Analysis of Current Market Performance and Project Status
Markets Today
Recommended Reading








